T1	p 87 105	nonsmokers . Women
T2	p 110 115	smoke
T3	p 426 470	users who smoke have greater reactivity have
T4	p 663 806	Sixty healthy women , half of whom had been using OCs for at least the previous 6 months , participated in the study . Approximately two thirds
T5	p 812 819	smokers
T6	p 946 956	nonsmokers
T7	p 1512 1519	women .
T8	p 1541 1557	nonsmoking women
T9	i 6 24	Oral contraceptive
T10	i 130 144	contraceptives
T11	i 147 152	OCs )
T12	i 585 593	nicotine
T13	i 615 617	OC
T14	i 868 930	12-hr nicotine deprivation or administration of nicotine gum .
T15	i 993 998	lipid
T16	i 1022 1026	rest
T17	i 1049 1060	speech task
T18	i 1435 1447	nicotine gum
T19	o 58 83	cardiovascular reactivity
T20	o 190 204	cardiovascular
T21	o 278 303	Cardiovascular reactivity
T22	o 551 576	chronic cigarette smoking
T23	o 579 584	acute
T24	o 625 660	cardiovascular and lipid reactivity
T25	o 959 1018	Heart rate , blood pressure , and lipid measures were taken
T26	o 1167 1239	smoking status or nicotine administration on cardiovascular reactivity .
T27	o 1304 1366	heart rate and diastolic blood pressure reactivity to stress .
T28	o 1467 1508	cardiovascular or lipid stress reactivity
T29	o 1585 1610	cardiovascular reactivity
T30	o 1614 1622	stress .